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Marine natural products, such as those encountered in sponges, are a prolific source of
drug leads. In cancer treatment, several sponges’ secondary metabolites have shown
potent cytotoxic activities. One of those is latrunculin A, a macrolide whose biosynthetic
production relying on a hybrid pathway involving polyketide synthases (PKSs) and
nonribosomal peptide synthetases (NRPSs) is still unknown. Considering the amounting
evidence that the sponges’ symbionts are the true producers of these compounds, it is
reasonable to search for the biosynthetic gene cluster of latrunculin A in the sponges’
metagenome. To achieve this goal, a multi-approach analysis was conducted in marine
sponges’ samples, some of them containing latrunculin A.
A sponge’s metagenomic DNA library of 3500 clones was produced. Obtaining high
molecular weight metagenomic DNA was a critical point which seems to have
conditioned successful vector packaging in λ phage particles. Instead, transformation of
the vector into the bacterial host was conducted through electroporation and heat-shock.
A preliminary PCR screen of the transformants revealed the presence of PKS genes.
In parallel, PCR screening of metagenomic DNA of diverse sponge samples was
conducted. Due to the hybrid PKS/NRPS origin of latrunculin A, focus was directed
towards the presence of PKS and NRPS genes. Several PCR-amplified sequences
exhibited homology to the ketosynthase (KS) domain of PKSs. Specific KS primers were
designed to latter screening of the produced metagenomic library.
Microbiome profiling of three different sponge samples was achieved through 16S rRNA
gene sequencing. Even though it was not possible to identify probable latrunculin A’
producers, an analysis of the biosynthetic potential of some of the most abundant
symbionts was performed. This demonstrated that further investigation of these sponges
for the discovery of novel compounds is promising.
Key words: marine sponges, latrunculin A, metagenomic library, biosynthetic gene
cluster (BGC), microbiome profiling.
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Resumo
Os produtos naturais marinhos, como os encontrados nas esponjas marinhas, são uma
prolífica fonte de fármacos. Em particular, no tratamento de cancro, vários metabolitos
secundários de esponjas têm mostrado potente atividade citotóxica. Um deles é a
latrunculina A, um composto de origem híbrida policetídica e peptídica não ribossomal
(PKS/NRPS), cuja via biossintética é ainda desconhecida. Considerando a evidência
crescente de que os verdadeiros produtores destes compostos são os simbiontes das
esponjas, é lógico procurar o cluster de genes biossintéticos da latrunculina A no
metagenoma das esponjas. Para atingir esse objetivo, foi planeada uma abordagem
múltipla de análise de amostras de esponjas marinhas, algumas delas contendo
latrunculina A.
A partir de uma esponja marinha, foi produzida uma biblioteca de ADN metagenómico
contendo 3500 clones. A obtenção de ADN metagenómico de alto tamanho molecular
foi um ponto crítico que parece ter condicionado o sucesso do empacotamento do vetor
no fago λ. Em vez disso, a transformação do vetor no hospedeiro bacteriano foi
efetuada por eletroporação e choque térmico. A presença de genes para sintases de
polipéptidos na biblioteca foi confirmada por rastreio inicial dos transformantes por PCR.
Em paralelo, realizou-se o rastreio por PCR do ADN metagenómico de diversas
amostras de esponjas. Devido à origem híbrida PKS/NRPS da latrunculina A, o foco foi
direcionado para a presença de genes PKS e NRPS. Diversas sequências amplificadas
por PCR demonstraram homologia para com o domínio ketosintase (KS) de sintases de
policétidos Primers específicos para KS foram desenhados para posterior uso no
rastreio da biblioteca metagenómica produzida.
O perfil microbiano de três diferentes amostras de esponjas foi obtido através de
sequenciação do gene ARN 16S ribossomal. Apesar de não ter sido possível identificar
prováveis produtores de latrunculina A, foi realizada uma análise do potencial
biossintético dos simbiontes mais abundantes. Esta demonstrou que parecem
promissoras futuras investigações destas esponjas para descoberta de novos
compostos.
Palavras-chave: esponjas marinhas, latrunculina A, biblioteca metagenómica, cluster
de genes biossintéticos, perfil do microbioma.
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1 Introduction
Natural products are small organic molecules produced by living organisms. Although not
being considered essential for growth or reproduction, they provide important ecological
advantages in the ecosystems where they are found [1]. Since the dawn of humankind,
these chemical substances rouse interest due to their interesting biological activities and
therefore have been used to treat diseases.
As the statistics show, natural products and their derivatives have been a productive
source of leads for drug development:  between 1981 and 2010, 34% of all medicines
approved by the Food and Drug Administration (FDA, USA) had a natural product origin
[2,3]. Examples of natural product-derived drugs which revolutionized medicine are the
antibiotics penicillin (18)1, erythromycin (6) and tetracycline (7),  the antiparasitic
avermectin (12), antimalarials like quinine and artemisinin, the cholesterol lowering
statins, immunosuppressants as cyclosporine (21) and rapamycin (22) and anticancer
drugs, particularly tubulin-binding agents, like taxol [4].
1.1 Marine natural products
Oceans are incredible diversified reservoirs of life forms. Considering that about 70% of
the Earth’s surface is covered by water and that life itself first appeared in this
environment, more than two billion years ago, it is safe to assume that a huge
biotechnological potential lies within these ecosystems. In the last 40 years, several
efforts were undertaken to explore these unique organisms and subsequently, their
associated compounds [5]. That resulted in several new classes of therapeutic agents
inspired by secondary metabolites produced by marine forms  with biological activities
towards cancer, infectious diseases,  inflammation, allergy, and many more [5,6]. In
recent years, research on marine natural products has observed a significant increase.
By 2010, more than 15,000 marine natural products had been discovered, with 8368 of
them only being recorded in the previous decade [7]. Interestingly, nearly 30% of all these
compounds were discovered on marine sponges, making these animals the richest
source of biologically active marine secondary metabolites [7,8]. In Table 1 are sumarized
some of the most significant discoveries of sponge natural compounds.
1 The number denotes for the order in which the molecular structures of the compounds are presented in
following figures.
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Table 1 Selected natural compounds discovered from sponges [8,9].
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Manoalide Luffariella variabilis Cyclohexanesesterterpenoid
Antiinflammatory,
antibiotic [23]
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Polyether
macrolide Antitumoral [24]
Latrunculin A (28) Latrunculiamagnifica
Thiazole
macrolide Antitumoral [25]





Cyclic peptide Antibacterial [27]
1.1.1 Marine sponges
The discovery of the nucleosides spongothymidine (1) and spongouridine (2) from the
caribbean sponge Tethya crypta by Bergmann et al. awoke the interest on marine
sponges in the early 1950’s [6,13,28]. These secondary metabolites provided the basis
for the synthesis of cytarabine (Ara-C) (3), the first marine-derived anticancer agent, and
the antiviral drugs vidarabine (Ara-A) (4) and zidovudine (AZT) (5) (Figure 1) [29]. This
marked the beginning of an intensive research on sponges, resulting in more than 4851
compounds reported until 2014 [7].
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Figure 1 Drugs developed from sponge natural compounds. Spongothymidine (1) and
spongouridine (2) inspired the development of an antitumoral compound - Cytarabine
(Ara-C) (3), and two antiviral drugs - Vidarabine (Ara-A) (4) and Zidovudine (AZT) (5).
Being on Earth for more than 580 million years, sponges, from the phylum Porifera, are
among the most ancient living Metazoa. More than 8,600 sponge’s species are reported
but is estimated that this number can round up to 15,000 species [30]. Sponges have
been broadly categorized in 4 classes: Calcarea, Demospongiae and Hexactinellida and
the recently recognized Homoscleromorpha [31]. These sessile animals are particularly
abundant in tropical seawater ecosystems although being also present in temperate
regions and in freshwater. Their ecological role in the benthic communities is crucial.
Occupying up to 80% of the available substrate, they provide habitat for several species,
take part in the biogeochemical fluxes and mediate the consumption and the release of
nutrients [30].
Sponges have a simple body structure which lacks tissues or sensory organs, placing
cells in direct contact with the surrounding seawater. That is crucial to their feeding
strategy as they daily pump large volumes of water (up to 24 m3 kg−1 sponge day−1) [32]
to sequester food particles and nutrients, leaving the expelled water essentially sterile.
Despite lacking solid physical defences, sponges possess chemically complex defence
mechanisms which allows them to live in extremely competitive environments [33].
Sponges  house highly diverse, yet specific, symbiotic communities which can constitute
more than 35% of the host’s biomass [34,35]. The consortia of bacteria, archaea,
unicellular algae, fungi, and viruses that reside within the sponge make essential
contributions to many aspects of the sponge’s physiology and ecology [8]. In fact, the
whole community can be treated as one ecological unit, termed the holobiont [30].
Interestingly, many microbial phylotypes seem to live exclusively within sponge hosts and
not in the surrounding seawater, making these communities often quite specific [8]. The
most prevalent sponge-associated microorganisms are represented in the phyla
Proteobacteria, Chloroflexi, Actinobacteria, Acidobacteria, Nitrospirae and in the
candidate phylum, Poribacteria which occurs almost exclusively in marine sponges [8,30].
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Even though much remains to be explained about the complexity of these associations,
our knowledge is rapidly improving. Regarding the ecological roles of symbiotic
organisms, one of the primary functions is related with host’s defence. The symbionts’
production of potent secondary metabolites seems crucial to the thrive of the physically
fragile sponges [7,36]. In fact, it is suggested that the invertebrate-derived metabolites
are actually produced by their microbial communities. This hypothesis, called the
symbiotic hypothesis of marine natural product synthesis, is further supported by the
bacterial like structure of many active compounds found in these environments. That has
led to a renovated interest on studying these microbial communities for the
bioprospecting of new drugs [37].
Nevertheless, the laboratorial cultivation of the bacterial symbionts offers a complex
challenge. It is estimated that less than 1% of all bacteria are culturable with conventional
techniques, a phenomenon called the Great Plate Count Anomaly [38], and about 70% of
all bacterial phyla identified so far contain exclusively uncultured species [39].
Additionally, even when symbionts’ cultivation conditions are achieved and
microorganisms are cultured, the absence of critical environmental triggers often leads to
the non-production of the target compound [37]. This helps to explain the strong focus of
the scientific community on genomic technologies in the study of the metabolic potential
of the sponges’ symbionts [8].
1.2 Microbial secondary metabolites
Sponges, and their associated microflora, produce complex secondary metabolites from
various biological precursors. Between the diversified types of synthesised compounds
are alkaloids, terpenoids, glycosides, phenols, phenazines, polyketides, fatty acid
products and peptides, amino acid analogues, nucleosides, porphyrins, aliphatic cyclic
peroxides and sterols [7,8]. However, the most important sponge natural products are the
polyketides and nonribosomal peptides (NRP). These compounds are synthesized by
large multifunctional polyketide synthases (PKSs) and nonribosomal peptide synthetases
(NRPSs) [40]. From a biosynthetic engineering perspective, the building-block-type
assembly of these compounds gives a major contribution for their production and
commercialization as drugs [1].
Interestingly, most of the microbial derived natural products are produced by metabolic
pathways encoded by chromosomally adjacent genes called biosynthetic gene clusters
(BGCs). These BGCs encode enzymes, regulatory proteins and transporters that are
necessary to produce, process and export specialized metabolites [41].
1.2.1 Polyketide synthases
Polyketides are the largest family of structurally diverse secondary metabolites,
synthesised in both prokaryotic and eukaryotic organisms. In human medicine, they are
the source of several biologically active compounds which target both acute and
degenerate diseases. As clinically relevant examples of polyketides we can point the
antibiotics erythromycin A (6) and tetracycline (7), the insecticide spinosyn A (8), the
cholesterol-lowering drug lovastatin (9), the antifungal compound amphotericin B (10), the
antitumoral agent pederin (11) and the anti-helmintic avermectin B1 (12) (Figure 2)
[42,43].
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Figure 2 Representative polyketides.
Polyketides are built from simple carboxylic acid monomers through programmed events
catalysed by PKSs. These giant multimodular enzymes have a biosynthetic mechanism
similar to fatty acid synthases. Each module carries a variable set of catalytic domains
and usually adds, by successive rounds of decarboxylative Claisen condensation, one
thioesterified acyl extender unit to the growing chain. The mostly used building blocks are
the residues of acetate (malonyl-CoA) and propionate (methylmalonyl-CoA), but more
complex units can also be used [44].
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PKSs are divided into three classes or types, according to the structural organization of
their domains. It is also important to acknowledge an additional class of hybrids with
NRPSs which will be discussed in Section 1.2.3 (Table 2) [45]. The type I and II PKSs
correspond to the previously classified enzymes of fatty acid biosynthesis [43]. Linearly
organized catalytic domains within large multifunctional enzymes are referred to as type I,
whereas in type II PKS, a complex of discrete monofunctional enzymes can be found.
Type II and III PKSs generate aromatic molecules, but use fundamentally different
approaches to construct the polycarbonyl chain and channel it into a cyclic fate. Besides
the enzyme structures, the mechanism of synthesis is another characteristic to classify
PKS. Depending on whether a module is used only once or repeatedly, PKSs can also be
classified as modular (non-iterative) or iterative [44].
Table 2 PKS types (adapted from [43,44]).
Type Extender units Organisms
Type I Various Bacteria and fungi










Even though the structural and organizational diversity of PKSs is tremendous, one has
marked the polyketide biosynthesis’ research since its discovery: the 6-
deoxyerythronolide B synthase (called ‘‘DEBS’’). This enzyme is responsible for the
macrolide erythromycin A (6) biosynthesis in the soil bacterium Saccharopolyspora
erythraea [46]. It was the first PKS to be discovered, in the 1990’s, and remains the most
intensively studied, serving as the prototypic to which all other modular PKS are
compared. DEBS has over 3000 amino acids and is composed of six elongation modules
flanked by a loading didomain and a thioesterase [43] (Figure 3). The modules are further
organized into three multimodular subunits: DEBS 1, 2 and 3 [42].
The prototypical PKS module, present in the DEBS, is composed by a ketoacyl synthase
or ketosynthase (KS), an acyl transferase (AT), and an acyl carrier protein (ACP). In the
initial step of the polyketide erythromycin (6) synthesis, the carboxy group of the starter
unit is chosen by the AT domain and it is covalently attached to a 5’-phosphopantetheinyl
SH group of the ACP. Then, the polyketide chain, transferred to the KS domain, is
elongated by a Claisen-type thioester condensation, and optionally further modified
depending on the domains present on the respective module. A ketoreductase (KR)
reduces the β-keto group to an alcohol function, a dehydratase (DH) removes one H2O
molecule, originating an α, β-saturated moiety, and an enoylreductase (ER) converts the
olefinic unit in a saturated system [44]. The PKS chain is thus transferred from module to
module until its final structure is achieved. Finally, a thiosterase (TE) hydrolyses and
releases the completed polyketide chain. In erythromycin (6) biosynthesis, the resulting
aglycone 6-deoxyerythronolide B (13) is further hydroxylated twice, glycosylated twice
and methylated on a sugar residue to form the fully active antibiotic compound [42].
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Figure 3 Erythromycin A (6) biosynthetic pathway by DEBS. Adapted from [42].
1.1.1.1. Type I PKSs
The already described DEBS is characterized as a cis-AT modular type I PKS, the most
intensively studied group of PKS enzymes. These enzymes are particularly attractive to
drug research due to the characteristic organization of the enzymatic machinery in
‘‘assembly lines’’. As each active site in modular type I PKSs is used only once during
polyketide biosynthesis, the order of the PKS modules correlates with the required
sequence of biosynthetic transformations [43]. This collinearity rule allows the
establishment of good predictions about metabolite structure, considering the enzyme
architecture, and the opposite situation is also effective [44]. Secondly, the specific
characteristics of these enzymes make them highly prone to drug research, as they are
very adaptable and amenable to pathway engineering [45].
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Another smaller and architecturally different type I PKS has been recently reported: the
trans-AT PKS. Differently from cis-AT PKSs, in these enzymes the ATs are encoded by
discrete genes and the modules lack AT domains. Instead, stand-alone ATs are
responsible for loading the extender unit malonyl-CoA to AT-less modules [44].
Altogether, unusual domain sets, appearing redundant modules and novel domain types
contribute to the non-linear assembly of these polyketides [43]. This makes metabolite
structure prediction a harder approach. The BGC for the antibiotic bacillaene (14) (Figure
4), present in several Bacillus species, is considered the prototype for this group of type I
PKS systems [47].
Figure 4 Bacillaene (14), a polyketide generated by a trans-AT PKS system.
1.1.1.2. Type II PKSs
Type II PKSs encompass discrete catalytic functions that are combined into a productive
complex. The ‘‘minimal PKS’’ includes the KSα, KSβ, and ACP domains, which perform a
defined number of chain-extension cycles to build the final polyketide (Figure 5). While
KSβ anchors the growing polyketide chain, KSα catalyses the Claisen type condensation
between the growing polyketide and incoming acyl-CoA subunits. The two KS subunits
have very similar sequences, being the central difference the absence of the active site
cysteine in KSβ. In type II PKSs, additional subunits can include KR, cyclases and
aromatases [44].
Figure 5 Type II PKS, an iterative system. Adapted from [43].
Typical primary products of type II PKSs are the polyphenols (Figure 6). Well-known
examples of this class are the antitumoral agent daunorubicin (15) and its derivative
doxorubicin (16) [47].
21
Figure 6 Daunorubicin (15) and its derivative doxorubicin (16).
1.1.1.3. Type III PKSs
The third PKS class links to the multifunctional enzymes of the chalcone synthase (CHS)
type, long been found in plants, but more recently have also been encountered in
bacteria and fungi [48]. Type III PKSs are composed by a multifunctional active site,
responsible for all the steps necessary to the polyketide synthesis.  In collaboration with
CoA-bound substrates, selects the starter unit, assembles the chain and promotes its
folding [44] (Figure 7).
Figure 7 Type III PKS, an iterative and ACP-independent system. Adapted from [43].
The well-known CHS starts from one p-coumaroyl-CoA and three malonyl-CoA units
which produces the tetraketide chalcone through subsequent Claisen ester condensation
reactions. CHSs provide the starting material for several biologically important
phenylpropanoid metabolites [44] (Figure 8).
Figure 8 Naringenin chalcone (17).
1.2.2 Nonribosomal peptide synthetases
NRPS are large, multimodular enzymes that assemble numerous structural and
functionally diverse peptides. These enzymes are mostly found in bacteria and fungi. The
starting material for the biosynthesis of NRPs are the 20 proteinogenic amino acids and
several nonproteinogenic amino and aryl acids [49]. These are sequentially incorporated
into the growing peptide chain by specific domains. According to the collinearity rule, the
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number and the order of the modules defines the number and the order of amino acids in
NRPs. More than 20 marketed drugs are NRP, including antibiotics like penicillin (18) and
vancomycin (19), the antitumoral compound bleomycin (20), and the well-known
immunosuppressant cyclosporine (21) [37,50] (Figure 9). NRPs are particularly
interesting for the development of new therapeutics mostly due to their excellent binding
properties, low off-target toxicity, and high stability [51].
Figure 9 NRP-based drugs.
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As observed in polyketide biosynthesis, NRPs are usually synthesised in three main
stages: building-block assembly, NRPS-mediated peptide assembly and post-NRPS
modifications. In the minimal NRPS elongation module, the adenylation (A) domain
selects, activates and loads the amino acid. The activated substrate is then transferred to
the thiolation domain, also called peptidyl-carrier protein (PCP). Finally, the condensation
(C) domain of the downstream module forms an amide bond between the elongated
chain and the activated amino acid, coupling to the upstream nascent peptide chain
[37,50] (Figure 10).
Figure 10 Peptide bond formation in NRPs. Adapted from [49].
During chain elongation, the growing peptide chain can be further modified. An
heterocyclization domain forms a thiazoline or oxazoline ring. These five-membered rings
can be further oxidized by oxidation domains into stable thiazole or oxazole heterocylces.
An epimerization domain can modify an L-amino acid to an D-amino acid. A
methyltransferase can transfer a methyl group from an S-adenosylmethionine to the
respective nitrogen or carbon atom. Dual/epimerization can occur, being responsible for
both epimerization and condensation reactions [37].
The final domain of an NRPS is usually a thioesterase which, through hydrolysis or
cyclization, releases the peptide chain from the assembly line. The resulting linear or
cyclic peptide can be further modified by post-NRPS reactions [49].
1.2.3 Hybrid PKS/NRPS compounds
Reflecting the inherent similarity between the two megasynthases, mixed PKS/NRPS
systems can also occur. PKS/NRPS-derived products can be divided into two main
classes, depending on the gene cluster organization. The compound can either be
synthesized individually by a NRPS or a PKS and eventually coupled into a hybrid final
product or produced by functionally connected PKS/NRPS enzymes, producing a hybrid
polyketide-peptide metabolite [37].
Several PKS/NRPS hybrids, such as the antitumoral agents rapamycin (22), known as
Sirolimus, and compound FK506, named tacrolimus (23), are clinically valuable natural
products [2] (Figure 11).
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Figure 11 Examples of PKS/NRPS hybrids.
Epothilones A (24) and B (25), which were originally detected in 1987 in the
myxobacterium Sorangium cellulosum [52], have a recognized potent antitumoral activity
due to its capacity of interfering in tubulin polymerization. The biosynthetic pathway for
the macrolactones epothilones (Figure 12) has been intensively studied [53], providing a
good starting point for the prospect of novel PKS/NRPS hybrids.
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Figure 12 Epothilone biosynthetic pathway. A PKS/NRPS mixed BGC in which one
NRPS module (EpoB) is surrounded by PKS modules. Adapted from [53].
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1.3 Uncovering the biosynthetic potential within marine sponges
As already described, the biotechnological potential within marine life is almost unlimited.
However, the survey of new drug leads has numerous inherent difficulties which have
delayed the full exploitation of marine resources. For example, several challenges were
found in sample collection and analysis. As the target compounds are normally not
abundant in the organisms, considerable amounts of sample for structural elucidation
were traditionally necessary. However, high throughput technologies are now allowing to
solve structures at a nanomolar scale [4]. Of notice, the powerful mass-spectrometry
methods and its associated advanced algorithms used in combination with flow-cell NMR
spectrometers [5].
1.3.1 Microbiome analysis
The development of molecular biology technologies revolutionized the approaches on the
research of organisms related with interesting natural products. For example, in the late
1980s, the advent of the polymerase chain reaction (PCR) involving the amplification of
the 16S ribosomal RNA (rRNA) gene, gave access to unknown unculturable bacteria [54].
The 16S rRNA gene is almost universally present in bacteria. It has nine highly
conserved regions which serve as universal primer binding sites for PCR amplification.
Simultaneously, the interspecific polymorphisms in its variable regions enable
phylogenetic reconstruction, with statistically valid measurements, for bacterial
identification and classification [55].
Nowadays, the direct sequencing of 16S rRNA variable regions is the most used
technique in the prospect of bacterial phylogeny and taxonomy [56]. It is a powerful tool
to visualize the sponge microbiome as also to phylogenetical compare organisms of
distinct species, locations and habitats [57-59]. Recently, a global survey was conducted
by Torsten et al., providing important conclusions on this matter [35].
Even though this tecnique has these advantages, it only provides a basic idea of the
metabolic potential of the sponge microbiome [59]. Other approaches based on the
functionality of genes are essential to understand the bigger picture and therefore are
briefly presented next.
1.3.2 Genomic approaches
The arrival of the 21st century shed a new light regarding bacterial genomes with the
complete sequencing of Streptomyces coelicolor strain A3(2) [60]. After more than 50
years of research, only three BGCs were known to exist in the genome of this natural
products-producing strain [1]. With the new sequencing approaches, it was discovered
that its genome harbours about 30 BCGs. This launched the idea that even well studied
strains may hold the potential to synthesize a larger number of compounds than those
analytically detected. From this recently found genetic potential, sprouted the concept of
natural-product genome mining, which concentrates the efforts on the analysis of the
genome [1]. As the cost of sequencing decreased, several bacterial genomes became
accessible. In addition, technologies like metagenomics and single cell genomics
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generate immense data to be analysed [42]. This creates interesting opportunities to
expand our knowledge on the secondary metabolism of the sponges’ symbionts [1,61].
Next-generation sequencing (NGS) is a DNA sequencing technology first introduced into
the market in 2005. In comparison with the most sophisticated capillary sequencers
based on the Sanger method, NGS can generate over 100 times more data [62]. It
produces shorter (e.g. 100-250) reads with an exceptionally high genome coverage [63],
providing a powerful tool to study DNA and RNA samples. Several different platforms are
commercially available: 454 Roche, Illumina, Ion Torrent and Helicos, all of them relying
on sequencing by synthesis. More recently, new sequencing methods based on single-
molecule sequencing are evolving, giving birth to third-generation sequencing
technologies like Pacific Biosciences and Oxford Nanopore [64].
1.3.2.1 Genomic mining
Genomic mining is the process of prediction and isolation of natural products based only
on the genetic information [65]. The classic approach searches for enzymes involved in
the biosynthesis of secondary metabolites, by screening the genome for genes within
BGCs [61]. Starting from a BGC is possible to infer the class of the natural compound
and, in some case, their structure [41].
However, the predictive accuracy of genome mining is intricately dependent of already
made experimental links between the BGCs and the products they encode. This is
generally accomplished by using laborious, and often challenging, laboratory experiments
such as gene knock-out or heterologous expression [1]. Once a gene function is
determined and experimental links are established, the detection of a similar BGC in
other strains can be used to predict the production of similar compounds [65].
Nevertheless, from the tens of thousands of compounds already identified by natural
product chemistry, the clear majority have not been linked to their respective BGCs [1].
This explains why bioinformatics approaches are still unable of forecast some BGCs [61].
In addition, the inherent complexity of the enzymes encoding for secondary metabolites
makes genomic mining a challenging task. Especially large and highly repetitive gene
clusters such as NRPS and PKS pathways are rarely fully assembled [65]. In addition,
the most promising bacteria on natural-product biosynthesis tend to have large genomes
and complex life cycles. Nevertheless, over the past two decades, the BGCs for a broad
range of polyketide and nonribosomal peptide natural products have been identified and
characterized [45].
1.3.2.2 Metagenomics
Over the past 5 to 10 years, the field of metagenomics has brought significant advances
in the study of microbial communities, shedding new light over unknown biosynthetic
pathways [66]. Metagenomics (also referred to as environmental and community
genomics) can be defined as the application of genomics to uncultured
microorganisms [67].
Metagenomic analyses can be based on a known sequence or on the functional genomic
potential of an environmental sample. When the sequence of a gene of interest is known,
PCR primers or hybridization probes are designed to search for the presence of desired
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genes. On the other side, a functional metagenomics approach can be employed when
sequence data is not known. After identified and isolated, the BGC of a specific
compound can be further studied by heterologous expression [9].
Metagenomic techniques focus on the analysis of complex DNA mixtures isolated from
entire samples or from enriched preparations. The ultimate goal is to properly assemble
individual DNA sequences into genes or genomes [68]. For example, in whole genome
shotgun (WGS) metagenomics, all DNA material of an environmental sample is randomly
sheared in small fragments, sequenced by NGS and assembled. This primer-
independent approach provides a significant amount of unbiased information on genes,
functions and organisms and a good estimation of microbial community composition and
diversity [69,70].
A widely used metagenomic approach is the construction of a metagenomic library. The
basic workflow starts with the extraction of the microbial DNA of an environmental
sample. After size selected, the collection of DNA fragments is inserted into an
appropriate vector which can be, among others, a fosmid (F1 origin-based cosmid vector)
or a bacterial artificial chromosome (BAC). The vector-insert constructs are then
transformed into a host bacterium, being Escherichia coli the most common [67,71].
Several large-insert (40–200 kb) fosmid and BAC clone libraries have been successfully
constructed from different sponges. A crucial advantage of these vectors is the capability
of including complete gene clusters or operons, simplifying the BGC screening
procedure [72]. These successful libraries led to the identification of several new PKS
genes, as for example in sponges Discodermia dissoluta [73] and Theonella swinhoei
[74], and new NRPS genes, like those identified in sponges Haliclona okadai [75] and
Aplysina aerophoba [76]. Interestingly, marine metagenomic libraries have also allowed
the identification of a wide range of biocatalysts, such as esterases, lipases, and
chitinases [9]. However, taking into accont all the efforts, the number of compounds
discovered from sponge metagenomic libraries is rather small. The numerous difficulties
in recovering high molecular weight (HMW) DNA from sponge symbionts to construct
large insert libraries can be pointed out as one of the main reasons for this [75].
1.4 State of the art
Between the myriad of possible applications of marine natural products, one has stood
out: its use in the anticancer therapeutic arsenal [77]. Currently, there are four marine
inspired commercialized anticancer drugs (two of them from sponges) and several
compounds in clinical trials [77]. Sponges are interesting sources of secondary
metabolites with cytotoxic activity. In fact, these compounds were found in 10% of all
sponge samples studied so far [78]. Nevertheless, the biosynthetic mechanisms of
several potential antitumoral compounds are still unknown. One example of this situation
is latrunculin A (28), a compound firstly described by Kashman and co-workers in the Red
Sea sponge Negombata magnifica (previously named Latrunculia magnifica) [25] whose
strong cytotoxicity activity  continues to arouse interest (Figure 13).
Latrunculin A (28) is a hybrid PKS/NRPS macrolide composed by a 16-membered ring
fused to a tetrahydropyran containing a 2-thiazolidinone moiety [79]. It reversibly binds to
actin monomers forming 1:1 complexes with G-actin, disrupting its polymerization [80]. In
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addition, this compound has showed antiviral and antibacterial activities, the capacity of
reducing intraocular pressure, inhibition of stress-activated MAP kinase (SAPK) pathway
and suppression of the hypoxia-induced factor (HIF-1) activation in breast cancer cells
[80]. Even though total synthesis has already been accomplished for latrunculin A (28),
the complete biosynthetic mechanism remains unknown.
Figure 13 Key pharmacophores of latrunculin A (28).
These are responsible for its actin binding bioactivity [81].
The search for an unknown biosynthetic pathway can embrace several different
approaches. In the specific case of sponges’ secondary metabolites, the construction of
metagenomic libraries with subsequent screening for targeted genes has proved its
success. The discovery of several BGCs based on the pederin (11) BGC is a good
example. Pederin (11) is a potent antitumoral agent produced by an uncultured bacterial
symbiont of Paederus fuscipes rove beetle and its BGC was the first complete
PKS/NRPS gene cluster of an uncultured bacterial symbiont to be identified [82]. Later,
Piel et al. successfully employed a pederin-informed PCR screening to identify PKS gene
cluster of onnamide A (28), an interesting compound found on the Japanese sponge
Theonella swinhoei [74]. As onnamide A (28) is very similar in structure to pederin (11),
primers for the amplification of PKS gene regions were successfully employed in the
identifcation of the candidate gene cluster [9,37].
Nevertheless, the use of universal degenerate primers to identify conserved PKS
domains has a significant downside: with general primers, too many diversified PKS gene
sequences are amplified, difficulting the process of screening for a specific gene cluster.
As a solution, Fisch et al. applied a nested PCR strategy in which degenerate primers are
firstly used to amplify the ketosynthase (KS) domain of the PKS. This is followed by the
application of a more specific primer pair. As a result, the BGC from the pederin (11)
relatives mycalamide (29) and psymberin (30) were identified from marine sponge
metagenomes [9,83] (Figure 14).
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Figure 14 Compounds whose BGC was discovered through a pederin (11) informed PCR
screening: Onnamide A (29) and mycalmide A (30) from T. swinhoei, and
psymberin (31).
1.5 Scope of the work
As exposed in last section, even though latrunculin A (28) has several characteristics that
picture its potential as a drug lead, its BGC is still unknown. The main goal of this work
was to provide new insights on its biosynthetic mechanism. To that end, it was aimed to
perform a metagenome analysis of sponges containing latrunculin A (28). The sponge
samples were collected in Bunaken National Park (Indonesia), in 2015 and 2016, and are
now part of the repertoire of the research group in which this work was developed
(professor Till Schäberle lab).
To achieve this goal, three different approaches were pursuit. Firstly, it was intended to
produce a representative metagenomic library of a sponge sample. Important insights on
the technical application of this method could be obtained, allowing further development
and adaptation of the already available knowledge on the specific matter.
Secondly, a structure-based PCR screening of the metagenomic DNA was implemented.
Latrunculin A (28) shares a carbon skeleton with the cytotoxic secondary metabolite
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epothilone A (24) [79] (Figure 14). In epothilone, the polyketide backbone is synthesized
by type I PKS and the thiazole ring is derived from a cysteine incorporated by a NRPS. In
addition, latrunculin A (28) shares common features with the potent anti-mitotic macrolide
rhizoxin (32), particularly the characteristic β-branch of trans-AT PKSs. As the
biosynthetic pathway of these compounds is well known (epothilone BGC is presented in
Figure 14), a gene targeting approach was developed. It was anticipated that PCR
screening of PKS and NRPS conserved domains would result in DNA fragments that,
after sequencing, could be subjected to bioinformatics analysis.
Figure 15 Chemical structures of epothilone A (24), latrunculin A (28) and rhizoxin (32).
Finally, additional insights on the sponges’ microbiome were provided through sponge’s
microbiome taxonomy profiling with 16S rRNA gene sequencing. The goal was to analyze
the possible advantages of this approach on the identification of compounds’ producers
and clarification of their BGCs.
Altogether, it was envisioned that the combined results of these approaches would
provide insights on the biosynthetic production of latrunculin A (28), increasing the
potential of its further development as a drug lead and, consequently, of its
biotechnological production.
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2 Materials and methods
This chapter focuses on the materials and methods used and applied throughout the
conducted work. First, a list of the materials is provided which is followed by a detailed
description of the carried procedures. Finally, software and databases essential for the
bioinformatic analysis of the produced data are presented.
2.1 Materials
2.1.1 Organisms
Sponge samples and bacterial strains used in this work are presented in Tables 3 and
4, respectively.
Table 3 Sponge samples analysed.
L+ and L- state for the presence, or not, of latrunculin A.
Sponge sample Source
Chdi15Bu13SL+ Bunaken, 2015
Chdi15Bu24+26S L+ Bunaken, 2015
Chan15Bu6S L+ Bunaken, 2015
Chdi16Sa3-5S L- Bunaken, 2016
Chan15Bu13S L- Bunaken, 2015
Specimens of sponges were previously collected by scuba diving and snorkelling in the
coastline of Bunaken National Park, Indonesia, in 2015 and 2016. The sampling
actions were performed under the “Indobio” Biodiversity and Health project framework.
Immediately after collection, they were preserved in 95% ethanol and kept at -20 ºC.
Previous work confirmed the presence of the compound of interest, latrunculin A, in
three of these sponges: Chdi15Bu13SL+, Chdi15Bu24+26SL+ and Chan15Bu6SL+
(Figure 16).
Figure 16 Underwater photographs of the sponge samples.
(a) Chdi15Bu13SL+, (b) Chdi15Bu24+26SL+, (c) Chan15Bu6SL+.
Most part of this work, however, was carried with sample Chi15Bu13S L+ (Figure 17).
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Figure 17 Chdi15Bu13S L+ sponge sample. (a) Recipient of conservation.
(b) Example of a cut for metagenomic DNA extraction in a petri dish.
Table 4 Bacterial strains used in this work.




F-deoR endA1 recA1 relA1 gyrA96






f80dlacZDM15 DlacX74 recA1 endA1
araD139 D(ara, leu)7697 galU galK λ-
rpsL nupG trfA tonA dhfr
Epicentre
Biotechnologies
2.1.2 Chemicals, solutions and media
Chemical reagents and solutions, antibiotics, buffers and culture media used in this
work are listed in Tables 5, 6, 7 and 8, respectively. Culture media were autoclaved at
121 ºC for 20 min.
Table 5 Solvents and reagents used.
Substance Manufacturer Substance Manufacturer
Agar Roth NaCl Merck
Chloroform Roth NaOH Merck
CTAB (Cetrimonium
bromide) Fluka Nitrogen, liquid Linde








triphosphates) Promega Phenol Merck
EDTA (Ethylenediamine-
tetraacetic acid) Sigma-Aldrich Potassium chloride Merck
Ethanol 99,8% p.a Roth SeaPrep Agarose Lonza
Ethidium bromide Roth Sodium acetate Merck
Gel Loading Dye Termo Scientific Sodium chloride Merck
Glycerol Roth Tryptone Roth
Glycerin Merck Tris-Base Roth
IPTG (Isopropyl-ß-D-
thiogalactopyranoside) Roth Tris-HCl Roth
Isoamyl Alcohol Roth Urea Roth
Isopropanol Roth Yeast extract Fluka
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Table 6 Antibiotics for selection of recombinant strains.
Antibiotic Mediaconcentration Stock Solvent Manufacturer
Carbenicillin 100 μg/ ml 100 x Water Fluka
Chloramphenicol 25 μg/ ml 1000 x Ethanol Fluka
Table 7 Buffers and solutions.
Buffer Composition Store
Phage dilution buffer (PDB)




Alkaline lysis solution I (P1) 50 mM Tris-HCl (pH 8.0)10 mM EDTA 4 ºC
Alkaline lysis solution II (P2) 200 mM NaOH1% SDS RT
Alkaline lysis solution III (P3) 3 M KOAc (pH 5.5) RT
Sponge Lysis Buffer 8 M urea      2% sarkosyl1 M NaCl     50 mM EDTA RT
TE Buffer 10 mM Tris-HCl (pH 7.5)1 mM EDTA (pH 8.0) RT
TAE Buffer 50x
242 g Tris-Base
57.1 ml acetic acid
100 ml 0.5 M EDTA
Add water to 1000 ml
RT




5 g yeast extract
10 g NaCl
Add water to 1000 ml of final volume (pH 7.5)
LB agar 15 g agar in 1 L of LB broth medium
SeaPrep agarose 5 g SeaPrep agarose in 1 L of LB brothmedium
2.1.3 Molecular biology materials and enzymes
MaxPlax™ Lambda Packaging Extracts (Epicentre Biotechnologies) were used to
package the pCC2FOS™ vector library. Molecular biology enzymes (Table 9) and
molecular weight markers (Table 10) were stored and used according to
manufacturers’ instructions. The list of primers employed in this work is presented in
Table 11.
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Table 9 Used enzymes.
Enzyme Manufacturer
Agarase Fermentas GmbH
GoTaq® G2 Flexi DNA Polymerase Promega
Fast-Link™ DNA Ligase Epicentre
T4 DNA Ligase Promega
T4 DNA Ligase New-England Biolabs
β-agarase I New-England Biolabs
Table 10 Molecular weight markers, used in agarose gel electrophoresis to size
estimation.
Table 11 List of primers.
Nr. Primer’name Sequence (5’- 3’)
Lenght
(bp) Source
- T7 TAATACGACTCACTATA 17 Promega- SP6 TATTTAGGTGACACTATAG 19
Primers for KS-domain of PKS
KF0001 Ks1up MGiGARGCiHWiSMiATGGAYCCiCARCAiMG 32 [83]KF0002 KSdn1 GGRTCiCCiARiSWiGTiCCiGTiCCRTG 28
KF0003 Ksup MGNGARGCNNWNSMNATGGAYCCNCARCANMG 32 [83]
KF0004 KSdn GGRTCNCCNARNSWNGTNCCNGTNCCRTG 28
KF0019 nKSfor1 TRATYGCNAAYCGNATYTCNYA 22
Previous
work2
KF0020 nKSrev1 GTRCCRTGNRYYTCRATRTANCC 23
KF0033 nKSrev2 GTNCCRTGNGCYTCRATRTA 20
KF0034 nKS for3 GCNYTNGARGAYGCNGGNTA 20
KF0040 KSupR MGNGARGCNNWNSMNATGGAYCCNCGNCANMG 32
Primers for A-domain of NRPS
KF0025 A2forA AARDSNGGNGSNGSNTAYBNCC 19 [73]KF0026 A8revA CKRWRNCCNCKNANYTTNACYTG 23
KF0027 A3Fpae GGWCDACHGGHMANCCHAARGG 22 [84]KF0028 A7Rpae GGCAKCCATYTYGCCARGTCNCCKGT 26
KF0029 A2forAi AARDSIGGIGSIGSITAYBICC 19 [73]KF0030 A8revAi CKRWRICCICKIAIYTTIACYTG 23
General Primers for 16S rDNA region
- fD1 CCGAATTCGTCGACAACAGAGTTTGATCCTGGCTAG 36 [85]
- rD1 CCCGGGATCCAAGCTTAAGGAGGTGATCCAGCC 34
2 Primers developed by Dr. Katja Fisch, available in the research group.
Molecular weight marker Manufacturer
1 kb DNA Extension Ladder Invitrogen
Gene Ruler 1 kb Plus DNA Ladder Thermoscientific
GeneRuler DNA Ladder Mix Thermoscientific
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The primers were purchased from Eurofins MWG Operin (Ebersberg, Germany). The
oligonucleotides were reconstituted in Tris-HCl buffer, diluted in TAE buffer to a
concentration of 100 ρmol/μl and stored at -20 °C.
2.1.4 Molecular biological kits and equipment
Molecular biology kits and equipment employed in this work are listed in Tables 12 and
13, respectively.
Table 12 Molecular biological kits.
Molecular biological kit Manufacturer
pGEM®-T Vector System I Promega
CopyControl™ HTP Fosmid Library
Production Kit with pCC2FOS™ Vector Epicentre Biotechnologies
Fast-Link™ DNA Ligation Kit Epicentre Biotechnologies
Wizard® Genomic DNA Purification Kit Promega
DNA Clean & ConcentratorTM Zymo Research Corporation
Zymoclean™ Large Fragment DNA Recovery Kit Zymo Research Corporation
QIAGEN Genomic-tip 100/G Qiagen
Fast Gene™ Gel/PCR Extraction Kit Nippon Genetics
Table 13 Equipment.
Material Manufacturer
Autoclave Varioklav® Labortechnik AG
Biometra T3000 Thermocycler Biometra GmbH
Centrifuge 5415 D Eppendorf
Centrifuge tubes (15/50 ml) TPP AG
Corning® 15ml, 50 ml PP Centrifuge Tubes Corning Incorporated
BioSpectrometer® Eppendorf
Eppendorf tubes 0.5, 1.5, 2 ml Eppendorf
Eppendorf µCuvette® G1.0 Eppendorf
Gel chambers Horizon™ 58 and Horizon™
11.14 Thermoscientif
Heraeus™ Fresco™ 17 Microcentrifuge Termoscientific
Heraeus™ Multifuge™ X1R Termoscientific
Inolab pH meter WTW
Kodak DC290 Kodak GmbH
Laminar Airflow Clean Bench BSB 4A (Hera
Safe, Class II) Heraeus
Milli-Q® Water System Millipore
Power Pac™ Basic Power Supply BioRad
Sub-Cell® Model 192 Cell BioRad
Thermal Mixer (TMix) Analytik Jena
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2.2 Methods
2.2.1 Metagenomic DNA isolation from sponges
To isolate the metagenomic DNA from sponges, the method proposed by the authors
Gurgui and Piel was applied [86]. Starting with the sponge sample conserved in 95%
ethanol, at -20 ºC, 1 to 30 g of tissue was cut with a scalpel. Under liquid nitrogen and
using a prechilled mortar and pestle, the sponge was ground to a fine powder. In some
cases, sterile sea sand was used to enhance the grinding.
To access the differences between the quality of metagenomic DNA collected with or
without previous concentration of the bacterial cells, an intermediate step was tried.
After grounding the sponge to a fine powder, the sample was separated into different
50 ml falcon tubes with artificial sea water. To pellet the sponge cells and other
detritus, a centrifugation (300 rpm, 30 min) was carried. The supernatant was then
transferred to new tubes and the bacterial cells were pelleted (10,000 rpm, 30 min). To
enhance cell lysis, the bacterial pellet was sometimes frozen.
One ml of sponge lysis buffer (Table 7) was added to each 100 mg of sponge tissue (or
10 mL to each bacterial pellet) and the mixture was incubated in a 60 ºC water bath for
20 min, with gentle mixing every 5 min. The sample was extracted at least twice with
phenol/chloroform/isoamyl alcohol (24:25:1) and the phases separated by
centrifugation (10,000 rpm, 4 ºC, 5 min). The aqueous phase was recovered and then
extracted with the same volume of chloroform. The DNA was then precipitated with two
volumes of ice cold 100% ethanol and 1/10 volumes of 3M sodium acetate (pH 7). After
half an hour at -20 ºC, the precipitate was centrifuged (10 000 rpm, 4 ºC, 30 min) and
the supernatant removed. The pellet was washed twice with 70% ethanol (10,000 rpm,
4 ºC, 15 min), air-dried and resuspended in 500 µl of Tris-HCl buffer (10 mM, pH 8.5).
The resulting extracted sponge’s metagenomic DNA was used through all the work. It
was the basis for metagenomic library production (Section 2.2.2), the template for the
screen and amplification of key biosynthetic gene clusters (Section 2.2.4) as well as the
template for 16S rRNA gene sequencing and consequent microbiome profiling.
2.2.2 Construction of a metagenomic library
The methodology for the construction of the metagenomic library was based on the
optimization proposed by Gurgui and Piel [86] for the protocol of the commercial kit
CopyControl™ Fosmid Library (Epicentre). In addition, several modifications were
introduced based on the results obtained during this study. We describe next the
general procedure. In Chapters 3 and 4, some alternative steps and their respective
results are presented.
2.2.2.1 DNA size selection by LMP agarose gel electrophoresis
The success of the fosmid library construction relies on the use of a correct DNA size
as the lambda phages are only capable of packaging DNA from 30 to 45 kb, being
36 kb the optimal size. Bearing this in mind, a gel electrophoresis is performed with low
melting point (LMP) agarose to select the desired DNA size from the previous isolated
metagenomic DNA. In addition, this step also removes contaminants which could
inactivate further enzyme reactions.
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A 20 cm long and 15 cm wide electrophoresis gel was set in a Sub-Cell® Model 192
(BioRad) chamber. To load 200-300 µl of metagenomic DNA, a larger well was
prepared on a normal electrophoresis gel comb by covering the small wells with tape.
This large well was flanked by two smaller ones, which were used for loading the DNA
size marker. A gel at 1% of peqGOLD Low Melt Agarose was prepared in 1x TAE
buffer and poured in the previously prepared electrophoresis chamber. The gel was
then cooled for 1 hour to achieve optimal consistence and afterwards the DNA sample
and the DNA size marker were uniformly loaded into the gel. First, the gel was resolved
at 50-60 V for 10 min to guarantee the transference of the DNA onto to the gel matrix.
Secondly, the voltage was lowered to 30-40 V and the gel electrophoresis was carried
out overnight.
After the run was completed, a 2-cm slice of gel was removed with a scalpel from both
sides of the gel. Each slice contained the whole marker lane and a small portion of the
well where the DNA sample was loaded. To minimize UV light exposure to the sponge
metagenomic DNA, only these two pieces were stained in a 1 μg/ml ethidium bromide
bath, for 20 min. Afterwards, the stained slices were exposed to UV and the position of
the top and the bottom of the 40 kb marker was marked with a scalpel. All the gel slices
were realigned, and the desired band of DNA was located and excised from the gel.
The cut-out gel slices were placed in 15 ml falcon tubes and molten at 65 °C for
15 min. The mixture was supplemented with 1 µl of GELase enzyme per 300 µl of
melted agarose and with pre-warmed buffer to 1x final concentration. The solution was
incubated in a 42 ºC water bath for 2 hours. After this time, the enzyme was inactivated
for 10 min in a 70 ºC water bath. A centrifugation step (10,000 rpm, 30 min, RT) was
performed to pellet any insoluble oligosaccharides and the supernatant, after being
transferred to a new falcon, was precipitated for 15 min at RT with 1/10 volumes of 3 M
sodium acetate (pH 7.0) and 2.5 volumes of 100% ethanol. The precipitated DNA was
pelleted (10,000 rpm, 30 min, RT) and twice washed with ice-cold 70% ethanol
(10,000 rpm, 20 min, 4 ºC). The supernatant was removed, the DNA pellet air-dried
and resuspended in 55 µl of Tris-HCl buffer.
2.2.2.2 Blunt-ending of size selected DNA
To clone the high molecular DNA fragments into the pCC2FOS™ vector, it is
necessary to end repair the genomic DNA because the vector contain blunt ends. This
step culminates in blunt-ended, 5'-phosphorylated DNA. The blunt-ending reaction
contained the following components:
8 µl 10x end-repair buffer
8 µl 2.5 mM dNTP mix
8 µl 10 mM ATP
x µl Size selected metagenomic DNA
4 µl End-repair mix (T4 DNA polymerase
and T4 polynucleotide kinase)
Add sterile water to 80 µl of final volume
The reaction mixture, after the removal of any air bubble, was incubated for 45 min at
RT. To inactivate the reaction in progress, 10 mM of EDTA were added and the mixture
was put at 70 ºC for 10 min. The metagenomic DNA was then precipitated with 120 µl
of H2O, 20 µl of 3 M sodium acetate (pH 5.2) and 140 µl of isopropanol, at RT for
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30 min. After that period, the mixture was spin in a microcentrifuge (top speed, 30 min,
4 ºC) and the supernatant (about 95%) was carefully removed. 500 µl of ice-cold 70%
ethanol were added to the pellet and another centrifugation step was carried out (top
speed, 10 min, 4 ºC). After total removal of the supernatant, the pellet was air-dried at
RT. Finally, 15 µl of Tris-HCl buffer (pH 8.5) was added and the DNA was resuspended
on ice for 30 min. An analytical 1% agarose gel was performed to assess the DNA
concentration and size.
2.2.2.3 Ligation of end-repaired DNA into the pCC2FOS™ vector
In this part of the protocol, it is optimal to have a 10:1 molar ratio of vector to
DNA-insert. Depending on the obtained quality of the blunt-ended metagenomic DNA,
a single ligation reaction will produce 103-106 clones. Differently from all the other
steps of the metagenomic library construction protocol, the used ligase enzyme was
different from the one supplied by Epicentre. The T4 DNA ligase from New England
Biolabs has proven to be more efficient and was, therefore, considered a safer choice
to assure an optimal ligation.
The following components were added to a PCR tube, in the order listed below, and
gently mixed by after each addition. The final reaction mixture was incubated at 16 ºC
overnight in a thermocycler.
1 µl 10x T4 DNA ligase buffer
1 µl pCC2FOS™ fosmid (0.5 µg/ µl)
x µl Blunt ended insert DNA
x µl T4 DNA ligase (New England Biolabs)
Add sterile water to 10 µl of final volume
On the next day, T4 DNA ligase was inactivated at 65 ºC for 10 to 15 min and the
packaging reaction was immediately performed.
2.2.2.4 Packaging of fosmid clones
On the day before the packaging reaction, a colony of EPI-300™-T1R E. coli was
inoculated, from a fresh LB agar plate, in 5 ml of LB broth supplemented with
10 mM MgSO4. The cell culture was grown overnight (30 ºC, 200 rpm). On the day of
the packaging, 5 ml of the ON culture were inoculated in 50 ml of LB broth
with 10 mM MgSO4. The cells were grown at 37 ºC (200 rpm) until an OD600nm of
0.8 to 1.0 was reached and stored at 4 ºC until being necessary.
For one packaging reaction, 25 μl of thawed MaxPlax™ Lambda Packaging Extracts
(Epicentre Biotechnologies) were transferred to a microcentrifuge tube placed on ice
and 10 μl of the ligated fosmid DNA were added. The solution was gently mixed by
pipetting (with cut tips) and incubated in a 30°C water bath for 90 min. After this time,
additional 25 μl of thawed packaging extract were added and the mixture was
incubated at 30 ºC for an additional 90 min period. Finally, phage dilution buffer (PDB)
was added to a final volume of 1 ml.
Before plating the library, it was necessary to determine the titer of fosmid clones
packaged in the phage particles to estimate their number in the library. Serial dilutions
into PDB were prepared (1:10, 1:102 and 1:103) and 10 µl of each dilution was added to
100 µl of previously grown EPI-300™-T1R E. coli cells.  After an incubation step at
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37 ºC for 20 min, the infected cells were spread onto LB plates supplemented with
12.5 µg/ml chloramphenicol. Subsequently to an ON incubation, the number of colonies
per plate as counted and the titer of the phage packaging was determined with the
following equation (1):
2.2.2.5 Library plating
The packaging reaction (1 ml) was mixed with 10 ml of previously grown
EPI-300™-T1R E. coli cells.  Next, a calculated volume of LB-Sea Prep Agarose (5 g/l)
was added, to obtain 1,000 cfus (colony forming units)/ml, as well as 12.5 µg/ml of
chloramphenicol. One-ml aliquots were distributed to 2 ml sterile screw-caps,
previously put on wet ice. After one hour, the vials were placed at 37 ºC for 16-18h.
Afterwards, the grown colonies were briefly vortex, 50% glycerol was added, and the
vials mixed by inversion. The metagenomic library was stored  at -80 ºC [87].
2.2.3 General workflow for the identification of key biosynthetic genes
The screening for biosynthetic genes of interest was conducted in metagenomic DNA
extracted from sponge samples (Section 2.2.1). First, PCR amplifications targeting KS
and A domains were performed (Section 2.2.4). After visualization of the PCR products
on an electrophoresis gel (Section 2.2.5), selected DNA fragments were purified
(Section 2.2.6) and ligated into the pGEM®-T vector (Section 2.2.7). The ligated vector
was transformed into α-Select Silver or EPI-300™-T1R competent E. coli cells through
chemotransformation by heat-shock (Section 2.2.8) and electroporation (Section 2.2.9),
respectively. Positive recombinants, selected through blue/white selection, were picked
and a whole cell PCR was performed. After gel electrophoresis visualization and gel
purification of the DNA products, their concentration and purity were checked (Section
2.2.10).  Finally, products would be sent to an external service (GATC Biotech AG) for
Sanger sequencing. The retrieved sequences were then subjected to a bioinformatics
analysis (Section 2.3).
2.2.4 Polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) is the method of choice for rapid amplification of
nucleic acid fragments, being therefore used for the screening of genes of interest. The
used primers were described above (Section 2.1.3); for details see the Results section.
In terms of reaction conditions, the applied method was adapted from Katja et al. [83].
A typical PCR reaction mixture was constituted by the following components:
10 μl 5x Green GoTaq® Reaction Buffer
2.5 μl 10x MgCl2-solution (25 mM)
1 μl DMSO
1 μl Primer 1 (100 μM)
1 μl Primer 2 (100 μM)
1 μl dNTPs (10 mM)
0.25 μl GoTaq® DNA Polymerase
2.5 μl DNA template
Add sterile water to 50 μl of final volume
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When degenerate primers were applied, 2.5 μl of each primer were used. In terms of
PCR conditions, the following program was set in the thermocycler:
1. Initial denaturation 94°C 2 min
2. Denaturation 94°C 30 s
3. Annealing 50°C 30 s 34 ×
4. Elongation 72°C 60 s
5. Final elongation 72°C 10 min
6. Cooling 4°C hold
The elongation time was estimated from the length of the target region (about
1 min/kb). Steps 2, 3 and 4 were repeated 34 times.
2.2.4.1 Optimization of PCR Conditions
In some cases, optimization of PCR conditions was necessary. For example, gradient
PCRs, with a temperature range of ± 4 ºC from a set value, were performed. These had
the purpose of guarantee the specificity of primer hybridization by using the optimal
annealing temperature. MgCl2 concentration was also adjusted through testing the
effect of different quantities on Taq polymerase activity.  Due to the DMSO capacity of
avoiding the formation of secondary structures in GC-rich templates, this substance
was sometimes added to the PCR reaction mixture. PCR reactions were
simultaneously performed with undiluted and diluted metagenomic DNA to reduce the
possibility of PCR inhibition by samples’ components.
2.2.4.2 Whole-cell PCR
This strategy was used to perform PCRs directly from bacterial colonies instead of
using isolated DNA. In blue/white selection, after inoculation of pCC2FOSTM-DNA
vector transformants in LB/carbenicillin/IPTG/X-Gal plates, positive (white) colonies
were picked and directly put in previously prepared PCR mixtures. The initial
denaturation step of the PCR was prolonged to 10 min to ensure the complete release
of the bacterial DNA, by cell wall and membrane disruption. The rest of the reaction
was performed as already described (Section 2.2.4).
2.2.5 Agarose gel electrophoresis
Gel electrophoresis is a standard method to separate, identify and purify DNA
accordingly to its size. In this study, gel electrophoresis was carried out essentially as
described by Sambrook and Russell [88], to analyse PCR products and extracted
genomic DNA. Standard gels were prepared by melting 1% agarose in 1x TAE buffer.
However, when DNA fragments of <500 bp were expected, an 3% agarose
electrophoresis gel was run for better visualization. Except for the PCR products which
were directly loaded on the gel, other samples were previously mixed with 6x loading
dye. Molecular weight markers were also applied to the gel to enable DNA size
estimation. Small gels were usually run 40 min at 100 V.  To reduce possible laboratory
contamination with ethidium bromide, gels were only stained after the electrophoretic
run. After 3-5 min in ethidium bromide bath, the background staining was removed by
passing the gel in a water bath.  The detection of DNA bands was performed by
exposing the gel to ultraviolet light. Gels were documented by Kodak DC 290 Zoom
Digital Camera System
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2.2.6 DNA recovery from agarose gels
After electrophoresis gel visualization, DNA bands of interest were extracted from the
agarose gel and purified using one of the following commercial extraction kits: DNA
Clean & ConcentratorTM (Zymo Research), Zymoclean™ Large Fragment DNA
Recovery Kit (Zymo Research) and Fast Gene™ Gel/PCR Extraction Kit (Nippon
Genetics). These kits were used accordingly with manufacturer’s instructions.
2.2.7 Ligation of PCR products
The pGEM®-T Vector System I (Promega) was used to clone PCR products. This kit
allows a complete ligation in just one hour, at room temperature. For optimal efficiency,
the ligation reaction was normally performed at 16 ºC, ON. A ratio of 3:1 (insert:vector)
is optimal. Therefore, the ideal amount of DNA insert was calculated using
equation (2):
The following ligation mixture was performed to standard ligations:
5 µl 2X rapid ligation buffer for T4 DNA ligase
1 µl pGEM®-T Vector (50 ng)
x µl PCR product
1 µl T4 DNA ligase
Ad sterile water to 10 µl of final volume
This vector has several advantages, one of them is the suitability for Sanger
sequencing using the general primers T7 and SP6.
2.2.8 Chemotransformation of competent cells by heat-shock
For each ligation (10 µl), two tubes of α-Select Silver Competent Cells (Bioline) were
thawed on ice. A 2-µl sample of the ligation was immediately pipetted to one tube and
the remaining 8 µl to the second tube. After 20 minutes on ice, a heat shock of 42 ºC
for 90 seconds was performed stimulate entry of the ligations products. Then, 500 µl of
LB broth were added and the cells incubated for 1 hour at 37 ºC, for plasmid
expression. In the case of transformation of DNA cloned into pGEM®-T vector, 50 µl of
the transformants were plated in a LB/carbenicillin/IPTG/X-Gal plate and the remaining
volume on a second plate. After an overnight incubation at 30 ºC, blue/white selection
would be performed to select for the recombinant plasmids. When the used vector did
not contain this selection mechanism, the transformants were selected in LB plates
with the appropriate antibiotic.
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2.2.9 Preparation of electrocompetent cells and electroporation
For the electroporation of ligation products into host cells, freshly made
electrocompetent cells were used. Both the induction of competence and the
electroporation steps were adapted from the method proposed by Tu et al. that relies
on the increase of transformation efficiency by working at room temperature [89]. For
the preparation of electrocompetent cells, a 1-ml overnight culture was diluted in
100 ml of LB medium. The culture was grown at 37 ºC for approximately two hours until
an OD600nm= 0.5-0.6 was reached. At this point, a centrifugation step (10,000 rpm,
5 min, RT) was done to pellet all bacteria. The cells were then washed with dH20,
centrifuged and the supernatant was removed. This washing step was repeated at
least three times to guarantee a reduced ionic strength of the medium. The cells were
resuspended in 300 µl of dH2O and 300 ng of DNA were added to the prepared cells.
The DNA-cell mixture was then transferred into 1 mm-gap cuvette and an electroshock
of a voltage between 1.2 kV and 2.5 kV was applied. LB medium (500 µl) was
immediately added and the cells recovered after 1-hour incubation at 37 ºC. At the end,
the cell suspension was spread onto LB plates containing the appropriate antibiotics.
2.2.10 Determination of DNA concentration and purity
A UV/VIS spectrophotometer (Biophotometer, Eppendorf) was used to determine
nucleic acid concentration and to access the quality of DNA solutions. At a wavelength
of 260 nm (A260) the absorption of 1.0 corresponds to a concentration of 50 μg/ml of
double stranded DNA. As aromatic amino acids of proteins show significant absorption
at of 280 nm (A280), the ratio A260/A280 is used to determine the purity of the sample.
A sample containing 100% of nucleic acids would have a A260/A280 ratio of 2.0. To
ensure DNA quality, values between 1.8 and 2 are desired. Depending on the
methodology involved, the concentration and quality of DNA was also estimated
through agarose gel electrophoresis by comparison with an appropriate DNA ladder.
2.3 Software and databases
Several bioinformatics tools were used during this work. Sequencing results and
corresponding chromatograms were visualized with the software Snapgene Viewer®
(GSL Biotech). Through it, a rapid analysis was performed to remove the nucleotides
corresponding to unspecific peaks. Then, VecScreen, an online tool provided by the
National Centre for Biotechnology Information (NCBI), was used to remove the vector
backbone from the nucleotide sequence. The treated sequences were then submitted
to Basic Local Alignment Search Tool (BLAST), also from NCBI, for homology
searches.
When primer designing was necessary, Clone Manager® 9 was the software employed.
For the deduction of amino acid sequences from the nucleotide sequences was used
ExPASy, an online tool of the SIB Bioinformatics Resource Portal, [90]. In addition,
some genomes of interest were analysed for BGC identification with the online platform
Antibiotics & Secondary Metabolite analysis Shell (antiSMASH) [91].
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2.3.1 16S rRNA gene sequencing
Part of this work consisted on the analysis of sponges’ bacterial composition by 16S
rRNA gene sequencing. Extracted metagenomic DNA (Section 2.2.1) was sent to
CeMET GmbH (https://www.cemet.de/en/), which performed all the steps from sample
quality control to the report of all bacteria found on the sample. The used NGS
technology was lllumina MiSeq and the reads were compared with NCBI database.
Taxonomic binning was performed using the lowest common ancestor (LCA) algorithm.
The sequencing results were analysed with the free software MEGAN V6.8.13
(Community Edition) [92]. This tool allowed taxonomic profile comparison between
DNA reads of different sponge samples.
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3 Results
Throughout this work, a total of five sponge samples were analysed. The number of steps
successfully performed with each one depended on the workflow and on the obtained
results. Table 14 is a summary of all the procedures applied to each sponge sample.
Particular emphasis was given to sample Chi15Bu13S L+, one of the three samples known
to have the compound latrunculin A.
Table 14 Proceedings carried out with each sponge sample during this work.
3.1 Metagenomic library construction
The approaches followed in this work empolyed sponge’s metagenomic DNA. Therefore,
the extraction of metagenomic DNA was the first step performed in the analysis of each
sponge sample. In sponge sample Chdi15Bu13SL+, for which a metagenomic library was
planned, special efforts were made to obtain HMW (>30 kb) DNA. Due to the difficulties in
achieving this goal, the procedure was repeated several times. This led to the
modification of method’s details in order to achieve optimization for the sample’s specific
characteristics. The amount of starting material, the concentration of bacterial cells and
the use of sterile sea sand are examples of optimized conditions. Figure 18 presents
electropheresis images of several extraction attempts. Metagenomic DNA of panel (c)
was selected for the subsequent steps of the protocol.
Steps successfully achieved





PCR screening 16S rRNA
sequencingKS genes 16S rRNA gene
Chdi15Bu13S L+     
Chdi15Bu24+26SL+    
Chan15Bu6S L+     
Chdi16Sa3-5S L-  
Chan15Bu13S L-  
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Figure 18 Different attempts of metagenomic DNA extraction from Chdi15Bu13SL+.
Electrophoresis gel images are shown. (C: control, unspecific DNA at 50 ng/µl).
In parallel with the application of the described method for metagenomic DNA extraction
(Section 2.2.1), the commercial kit Qiagen genomic tip 100/G was tried. Nevertheless,
this did not solve the problem in obtaining HMW DNA (Figure 19). In addition, the quality
of the extracted DNA proved to be lower due to the considerable amount of fragmented
DNA (smear in the gel).
Figure 19 Metagenomic DNA extraction from Chdi15Bu13SL+ with Qiagen Genomic Tip.
Starting material: 2 g. Electrophoresis gel image is shown.
After the extraction of the metagenomic DNA, the subsequent parts of the protocol were
carried with minor adjustments. Figure 20 exhibits a sequence of electrophoresis gels run
at the end of each step. To avoid DNA fragmentation, extra care was taken when
handling metagenomic DNA. The use of cut tips, low centrifugation rates and the
avoidance of repeated pipetting of the DNA, are examples of measures taken.
Nevertheless, a decrease in DNA size from each step to the next is observed.
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Figure 20 Electrophoresis gels of metagenomic DNA after different steps of
Chdi15Bu13SL+ library construction. (a) After metagenomic DNA extraction.
(b) After purification and size selection by running on a LMP agarose electrophoresis gel.
(c) After blunt-ending reaction.
The ligation of the size-selected and blunt-ended metagenomic DNA into the
pCC2FOS™ vector was another critical point. Several tries were performed until the
reaction’s product run in an agarose electrophoresis gel was compatible with the ligation
step. Figure 21 (b) presents the last, and only, successful group of ligation reactions.
Even though a 10:1 molar ratio (vector:DNA) is described as optimal [86], multiple
combinations were simultaneously tried to improve the chances of achieving a positive
outcome. Surprisingly, all the 5 combinations had bands compatible with a ligation
product. Nevertheless, as they were all slightly different from each other, it was not
possible to determine which ones had the optimal ligation.
Figure 21 Ligation of fosmid control DNA and metagenomic sponge DNA into
pCC2FOS™ vector. Reactions were done at 16 ºC for 16 h. (a) Agarose electrophoresis
gel of the negative control of the ligation (Fosmid control DNA (42 kb) and pCC2FOS™
(8181 bp)). (b) Agarose electrophoresis gel of the successful ligation of blunt-ended DNA
from Chdi15Bu13SL+ in pCC2FOS™ vector. (c) Scheme of the ligation reactions
presented in (b).
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The next step in the metagenomic production workflow is the packaging of the ligated
vector into the lambda phage (Section 2.2.4). Two attempts were performed with ligation
A and B. The putative phages of the two packaging reactions were used to infect EPI-
300™-T1R E. coli cells, with subsequent plating on selection agar plates. However, both
attempts failed (no colonies at all for ligation B and two colonies in 1:10 dilution plate for
ligation A).
To confirm if the method was being correctly applied, a control DNA was used in the
same way as the metagenomic sponge DNA (from the ligation reaction until the
inoculation on agar plates). This positive control gave a titer of 1,4x107 cfu/ml (Figure 22).
Considering the data described in the protocol for CopyControlTM Fosmid Library, which
states that a titer of >1x107 cfu/ml should be expected, the procedure was being properly
conducted.
Figure 22 Positive control: EPI-300™-T1R E. coli cells after transduction of
pCC2FOS™-fosmid control DNA, packaged in λ-phage.
The cells, plated in LB/chloramphenicol plates, gave a titer of 1,4x107 cfu/ml.
(a) 1:10 dilution. (b) 1:103 dilution.
After the absence of results from the application of the conventional method (lambda
packaging) a novel approach was engaged. This consisted on an adaption of the
traditional cloning methods for the transformation of bacterial competent cells:
electroporation and chemotransformation. These two methods were performed
essentially as explained in Sections 2.2.8 and 2.2.9 with ligations D and E (Figure 21).
The 10-µl Ligation D was divided in 2- and 8-µl samples that were used to separately
transform α-silver E.coli cells, through heat-shock. Ligation E, also with 10 µl, was divided
in 5 different samples (0.5, 1, 2, 3 and 3.5 µl), which were used in 5 electroporations of
EPI-300™-T1R E. coli cells. After the transformation procedure, each mixture was
supplemented with 500 µl LB and incubated for one hour to allow cell recovery. After that,
200 µl of each culture were plated in LB/chloramphenicol and incubated ON. On average,
the number of colonies resulting from the 7 transformations was around 200 cfu/plate.
The transformants resulting from chemotransformation were called α2 and α8, whereas
those arising from electroporation were designated E0.5, E1, E2, E3 and E3.5.
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Figure 23 Workflow diagram of all the steps from transformation of host cells with
pCC2FOS™-metagenomic DNA to the production of the metagenomic library.
(a) Transformation of ligation D into α-silver cells by heat shock and electroporation of
ligation E in EPI-300™-T1R cells. (b) Transformants were confirmed as having KS
genes (c) Plating of the rest of the transformed cells (d) All the colonies on the
LB/chloramphenicol plates were used for the production of the library.
Before proceeding to the construction of the library, a KS PCR was carried to verify if the
fosmid’s inserts contained sequences of interest. To achieve this goal, whole-cell PCR
was conducted in colonies picked from the seven transformation plates. Primers listed in
Table 11 for KS domain of PKS were used.  Even though it was not possible to obtain
PCR products for all the four primer pairs, a clear band, compatible with the use of the KS
primers KF0019 and KF0020, was obtained for each group of transformed cells, thus
confirming the presence of KS sequences (Figure 24).
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Figure 24 Example of PCR product of the KS-screening of the transformants.
A 500 bp band is visible on first lane, corresponding to product of primer pair
KF0019/KF0020. The following lanes, with no amplification products, correspond to PCR
reactions with primer pairs KF0019/KF0033, KF0034/KF0020 and KF0034/KF0033.
Agarose electrophoresis gel is shown.
After confirming the presence of KS sequences in the transformants we proceeded with
the production of the metagenomic library. For that, the remaining volume (300 µl) of the
transformation mixtures described above was plated in LB/chloramphenicol plates. The
total colonies from each transformation, from both the two plating events, were collected
to tubes containing 500 μl of LB. To these were added 10 ml of LB/Sea Prep agarose and
chloramphenicol to a final concentration of 12.5 µg/ml. The content of each tube was
divided in nine 2-ml screw-caps. After overnight incubation, each tube was vortexed and
an aliquot of each was removed to produce a pool. A 500-µl volume of 50% glycerol was
added to each tube of the library, which was finally stored at -80 ºC. In the end, the
metagenomic library was composed of 63 vials and 7 pools (Figure 25). A total of 3500
colonies were collected to produce this library.
Figure 25 Chdi15Bu13SL+ metagenomic library in 3D culture.
(a) 2-ml vials on wet-ice after aliquoted with the transformants in LB/Sea Prep Agarose
supplemented with chloramphenicol (b) Incubation of the cultures at 37 ºC, in the
conservation box.
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3.2 Screening for biosynthetic gene clusters (BGCs)
A metagenomic survey of key biosynthetic genes in different sponge samples was
performed.  This consisted on the use of primers based on KS and A domains since their
sequences are the most conserved among PKS and NRPS domains, respectively. After
PCR amplification of target regions, PCR products were cloned. Some of the clones were
sequenced and analysed by the blastx program.
3.2.1 Polyketide synthases
The identification of PKS genes in the sponge’ metagenomic DNA was performed
through a nested PCR approach as described by Katja et al. [83]. First, general KS
primers (KF0001/KF0002 and KF0003/KF0004) originated 700 bp fragments. With these,
a second PCR was conducted, resulting in sequences with 480 bp (primers pair
KF0019/KF0020 and KF0019/KF0033) and 600 bp (primers pair KF0034/KF0020 and
KF0034/KF0033). In Figure 26 it is possible to observe these bands, which have a slightly
higher molecular size than the abovementioned due to the presence of vector sequences.
Figure 26 KS PCR screening of Chdi15Bu13SL+ metagenomic DNA.
Electrophoresis gel image is shown.
This procedure, which was applied in four sponge samples, retrieved a total of 30
different PCR products. After sequenced and analysed in blastx, 16 of them were
identified as homologous to PKS genes (Table 15). Some sequences were identified in
more than one fragment, providing a perspective in terms of their possible abundance in
the metagenomic DNA. Of notice, sequence B.1920.5, with two more identical fragments
(B.1920.4 and B.1933.4), and C.2.1933 with one equivalent sequence (C.2.3420).
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72 100 5,00E-71 AGS06824.1
A.1920.2 588 Polyketide synthase[Streptomyces cattleya] 66 99
1,00E-
55 WP_014144300.1
A.1920.5 495 Ketosynthase [Bacillus sp.] 72 95 1,00E-80 SAJ35041.1







47 79 4,00E-09 WP_039937000.1
A.1933.I 341 Polyketide synthase[Cylindrospermum stagnale] 57 38
1,00E-
06 WP_015211419.1
A.2-T7 535 Modular polyketide synthase[uncultured bacterium] 57 83
5,00E-
21 AAW84195.1













[uncultured bacterium] 98 69
5,00E-
27 AAW84195.1





















C.2.1933 736 Polyketide synthase, partial[[Oscillatoria] sp. PCC 6506] 65 99
1E-
102 ACJ46057.1





[[Scytonema hofmanni] UTEX B
1581]
67 98 4,00E-89 WP_063628697.1














53 90 1,00E-24 SFW64528.1
D.3334.8 357 Ketosynthase [unculturedbacterium] 58 83
2,00E-
28 AGK63336.1
Regarding the sponge from which the metagenomic library was constructed
(Chdi15Bu13SL+), six different KS sequences were retrieved with this PCR-based
approach. The organisms from which the homologues belonged were from the following
phyla: Proteobacteria (two sequences), Actinobacteria (two), Cyanobacteria (one) and
Firmicutes (one).
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After acknowledging the presence of different PKS gene fragments in the Chdi15Bu13SL+
hologenome, next we planned to screen for the whole gene clusters from which each
sequence belongs. Using the first six sequences listed in Table 15 as a starting point, six
primer pairs were designed with Clone Manager software (Table 16). These will
specifically amplify the obtained KS sequences from the clones of the metagenomic
library. Consequently, it will be possible to identify the fosmids in which they are included.
Hopefully, through the complete sequence of this fosmids it will be possible to the identify
the gene clusters from which each sequence belongs. From this point, we are closer to
know complete BGCs within the metagenome.
Table 16 Designed primers for BGC screening of the metagenomic library.













3.2.2 Nonribosomal peptide synthases
A PCR strategy with three different primer pairs for the A-domain (Table 11) was applied
in the survey of the sponges’ metagenome for NRPS genes. With this approach, a total of
10 different PCR were obtained and sequenced.  Unfortunately, none of the 10
sequences revealed significant homology with NRPS genes.
3.3 Sponges’ microbial composition
In this section, the microbiome of different sponge samples was analysed. First, a
preliminary PCR screening of the sponges’ metagenomic DNA was executed. In addition,
16S rRNA gene sequencing was performed in two latrunculin A producing sponges and
in one sponge in which this compound was not detected.
3.3.1 16S PCR screening
PCRs with universal 16S primers (Table 11) were performed in metagenomic DNA of
sponges Chdi15Bu24+26SL+ and Chan15Bu6SL+. A total of six PCR fragments were
Sanger sequenced with both forward and reverse primers, retrieving a total of 12
sequences, 10 of them with homologies with sequences in the NCBI database (Table 17).
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3.3.2 16S rRNA gene sequencing through NGS
Metagenomic DNA samples from Chdi15Bu13SL+ and Chan15Bu6SL+ (latrunculin A
containing sponges) and Chan15Bu13SL- were analysed through 16S rRNA gene
sequencing, performed by CeMeT GmbH with NGS Illumina MiSeq system. The lowest
ancestor algorithm was used to compare the sequence data with the NCBI taxonomy
database. A total of 29894 assigned reads were retrieved for Chdi15Bu13SL+, 21537 for
Chan15Bu13SL- and 17133 for Chan15Bu6SL+. MEGAN software was used to graphically
exhibit the data (Figure 27).
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Figure 27 Cladogram of the 16S rRNA taxonomic profiling of Chdi15Bu13SL+ (blue),
Chan15Bu13SL- (orange) and Chan15Bu6SL+ (green) collapsed at ‘Class’ level.
The results are presented in log scale (total of 51,515 assigned reads, normalized to
17,133 per sample).
The higher phylum diversity was found in Chdi15Bu13SL+, with 19 in total. In this sponge,
the three most abundant phyla were Proteobacteria (21.69%), Actinobacteria (8.46%)
and Firmicutes (6.43%). In Chan15Bu6SL+, Proteobacteria (80.34%), Firmicutes (1.42%)
and Actinobacteria (0.63%) were dominant. In Chan15Bu13SL-, they were the
Proteobacteria (28.94%), Actinobacteria (10.15%) and Chloroflexi (5.29%) phylum
(Figure 27).
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Figure 28 Taxonomy profile, at ‘Class’ level.
(a) Chdi15Bu13SL+, (b) Chan15Bu6SL+, (c) Chan15Bu13SL-.
As graphically displayed in Figure 28, at class level, Chdi15Bu13SL+ and Chan15Bu13SL-
have a similar taxonomical profile. The similarity between them is further demonstrated in
Table 18, in which are presented the most abundant bacterial species in each sponge.
They both possess Candidatus Solibacter usitatus as the most predominant bacteria and
Planktothrix suspense as the second. Differently from the highly diversified microbiome of
Chdi15Bu13SL+ and Chan15Bu13SL-, in the sponge Chan15Bu6SL+ only four main
classes are found. Almost 75% of its reads are assigned to the class
Gammaproteobacteria.
Table 18 The first three most predominant bacterial species in each sponge.

















sporoproducens 0,58% Vibrio navarrensis 0,84%
Three bacterial species were only identified in latrunculin A containing samples:
Coprococcus eutactus, Coprobacter fastidiosus and Sporobacter termitidis. The available
genome of the closest strains was analysed in the antiSMASH platform. However, no
potentially interesting BGCs were retrieved.
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4 Discussion
4.1 Metagenomic library construction
The construction of a sponge metagenomic library poses a complex challenge. Even
though several groups [74,93] have successfully tackled this issue, the process itself
continues to be very laborious and time-consuming [94]. The main refered challenge is
the difficulty in recovering high molecular weight (HMW) DNA. One of the main reasons is
the fact that every starting sample is different from the ones previously used because of
the spatial-temporal heterogeneity of the sponge and associated organisms. Factors like
polysaccharide content, the amount of sponge-associated bacteria and the sample’s
state of conservation make optimization mandatory for each particular case.
It is important to account for the impact on DNA quality of sample collection and
preservation, especially when the goal is to produce a metagenomic library. In this case,
the sponge samples were collected by SCUBA diving and preserved in 95% ethanol. In
an ideal scenario, right after sponge gathering, the bacterial DNA would have been
immediately extracted and the metagenomic library prepared. However, this analysis was
only performed aproximately six months after collection. It is hypothesized that this could,
in part, justify the difficulties on getting HMW DNA.
4.1.1 Metagenomic DNA isolation
As already stated, the main challenge when constructing a metagenomic library is the
extraction of HMW DNA (> 30 kb), with good yield and integrity. Considering that each
step contributes with more DNA fragmentation, it is crucial to start with HMW DNA [95].
As described in Section 3.1, this was a critical point of this work which required
optimization. Thereby, comments on the impact of protocol’s conditions are here
exposed.
For one library production, a considerable amount of DNA must be initially collected, as
the rate of DNA loss in each step is high. Theoretically, from 1 g of sponge tissue it is
possible to collect enough DNA for one library production [86]. Nevertheless, due to the
difficulty on recovering sufficiently concentrated DNA, higher quantities of initial sample
were tried (1 to 30 g). The best results were obtained with quantities ranging from 3 to 8 g
and, from this point, higher amounts of sample were not proportional to a procedure
improvement. As the complete bacterial cell lysis is a key factor in the DNA isolation, it
can be presumed that higher cell densities decrease the efficiency of the sponge lysis
buffer. Other strategies were attempted to maximize cell lysis: the freezing of the bacterial
pellet and the usage of sterile sea sand on the grinding process. The latter culminated in
a more concentrated DNA. That was expected since the fragmentation of the sponge
structures helps to free the symbionts, resulting in a better effect of the lysis buffer.
Since the bacterial DNA is the object of the study, it is hypothesized that the separation of
the symbionts’ genomic material from the sponge DNA could improve subsequent
enzymatic reactions and facilitate heterologous expression [93]. Even though PCR
primers will only bind to the specific sequences of bacterial DNA, host genomic material
interferes with the quality of the process by allowing more unspecific binding.
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Nevertheless, bacterial cell concentration through centrifugation had a negative impact on
DNA size and, because of this, this approach was dropped.
Gurundi et al. proposed the addition of a CTAB step for the removal of the polysaccharide
content, usually high in sponge samples [86]. Its presence can lead to incomplete
enzymatic reactions, in the following phases of the protocol. However, this step was
ignored due to coprecipitation of CTAB with DNA, and its subsequent loss. Additionally, it
is presumed that Chdi15Bu13SL+ has low polysaccharide content.
Finally, the Qiagen genomic tip kit failure in extracting good quality metagenomic DNA
might be caused by the non-specificity of this kind of commercial kits, which are designed
to work on a roll of different samples.
4.1.2 pCC2FOSTM-metagenomic DNA vector transformation into host cells
pCC2FOSTM is a cos-based vector which allows packaging by lambda phage for
subsequent transduction of E. coli cells. The correct packaging of the vector into the
lambda phage particles can only be confirmed through its transduction to suitable
bacterial cells, with the subsequent colony growth in LB/chloramphenicol plates. When
no positive results are obtained, it is difficult to assess the cause. For this reason, a
control procedure was carried with Fosmid Control DNA (Epicentre), which gave a
positive result. This confirms that the method was being properly performed. Hence, the
most probable cause for failure in alpha packaging and, consequently, in cell
transformation is the reduced size of the metagenomic DNA. This constrains its
packaging into lambda phage heads [95]. Ultimately, it can lead to the production of
vector-less, non-infectious phage particles.
Using an unconventional approach, based on transformation by heat-shock and
electroporation, it was possible to deliver vector pCC2Fos-metagenomic DNA to E. coli
cells. Metagenomic libraries prepared with the same experimental setup but with
properly-functioning lambda packaging are described as being constituted by
80,000 clones [82] or 410,000 clone [83]. Compared with these libraries, this approach
originated significantly less clones (3500 clones). This can pose an impediment in the
future screening of the library for the BGC of interest [72] as the size of a polyketide gene
cluster can vary from 10 to 100 kb [96]. Very often, these are separated in distinct
fosmids being necessary to identify and sequence several clones [37]. Therefore, a larger
metagenomic library is required to improve the probabilities of succeeding in a future
screening. Nevertheless, it was decided to proceed with these transformants because the
restart of the whole procedure would be time-consuming.
Future screening of the produced metagenomic library will start with primers (Table 11)
designed from KS sequences already found in Chi15Bu13SL+ sponge (Section 3.2.1).
This process can guide to the identification of potential latrunculin A biosynthetic genes
as well as to BGCs of known or yet-unidentified polyketide products.
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4.2 Screening for biosynthetic gene clusters (BGCs)
While constructing the metagenomic library, it was intended to evaluate the biosynthetic
potential of the sponges’ samples in study. That was performed using well-described
primers for the KS domain of PKSs and for the A domain of NRPSs. Even though it was
not possible to obtain NRPS sequences, this PCR strategy confirmed the presence of
polyketide synthases’ genes in all the sponges screened. In addition, the knowledge of
the sequences within sponge Chdi15Bu13SL+ allowed the design of specific primers
(Table 16) for the later screening of the constructed metagenomic library. Its future use
can be specially interesting to uncover the full BGCs from which some KS sequences
belong.
It is important to acknowledge the bias associated with PCR-based methods. Even
though this approach provides interesting insights into sponge’s microbiome as well into
some of the BGCs present in the environmental DNA, it only gives a diminish perspective
of the sample’s full metabolic potential [96].
A structure-based approach was used to target specific features of the compound
latrunculin A. Polyketides synthetized by trans-AT PKSs normally contain a characteristic
carbon branch at the β position, as observed in latrunculin A (28) and rhizoxin (32)
(Figure 29). The primers used in the KS nested PCR are specific for the acyl transferase
domain. For example, primer KF0034 targets the EDAGY motif which is conserved in
84% of all trans-AT PKSs [83]. In the Supplementary material chapter, where is
presented the translation to amino acids of the nucleotide sequences, it is possible to
identify this motif, among others.
Figure 29 Position of β-branch on the molecular structures of
latrunculin A (28) and rhizoxin (32).
The homologue of the fragment A.3334.3, with 72% identity, is an interesting sequence
for a deeper analysis. Candidatus Profetella Armatura is a Betaproteobacteria with a
characteristic small genome, 15% of which encoding for a pederin-like polyketide toxin
named diaphorine [97]. The indicated identity shows that the sequence retrieved from
Chdi15Bu13SL+ metagenome probably belongs to a similar, but not the same, gene
cluster. Together with the knowledge that diverse pederin-related compounds show
potent bioactivities, these are enough points of interest to pursuit the study of this
sequence.
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Considering than only two sequences were found more than once in the sequenced
bacterial clones, a relative high diversity of PKSs seems to exist in this sponge’s
metagenome. It can be estimated that further KS-PCR screenings would result in more
different sequences. This could be an interesting approach for future work.
4.2.1 NRPS-based PCR screening
Due to the hybrid origin of latrunculin A, a different approach, based on PCR screening
for the highly conserved A-domain, was attempted. The lack of homologies of the
obtained PCR products with NRPS genes can be analysed from separate perspectives.
By solely considering these results, it could be stated that NRPS genes are not abundant
in the sponges’ metagenome and therefore are not easily depicted through the applied
PCR strategy. Nevertheless, there is no guarantee that the optimal PCR conditions were
achieved for the used primers. If inadequate, this can inhibit the reaction and be
responsible for the verified absence of PCR products. Therefore, no significant
conclusions can be retrieved from these results.
4.3 Sponges’ microbial composition
As already stated in Section 1.3.1, the characterization of the host microbiome is a crucial
step towards the full comprehension of these intricately connected systems. In this
section, sponges’ symbionts will be analysed. Nevertheless, as these approaches are
based on metagenomic DNA extracted from sponges’ portions, it is necessary to access
the associated and inherent bias. Even though it was tried to include representative
segments of the sponge (longitudinal cuts, exemplified in Figure 17 (b)), there is no
guarantee that it contains representatives of all sponge’s microorganisms. Only through
more sampling would be possible to discard this bias.
In terms of the analysis of general 16S screening, reduced conclusions could be draw. All
the PCR fragments, apart from B.1.16S, were homologous to uncultured bacteria. This is
an expectable result because the number of environmental rRNA gene sequences in the
databases is considerably higher than the number of sequences from cultivated
microorganisms [98].
This was only a preliminary attempt to characterize the sponges’ microbiome as it is an
inexpensive and fast approach to retrieve data. The following method, 16S rRNA gene
NGS sequencing, is the most used technique to phylogenetically characterize a
metagenome due to its capacity of revealing most of the microorganisms present on a
sample.
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4.3.1 16S rRNA gene sequencing through NGS
The main goal of this approach was to verify if it existed a major difference in the
microbiome composition of two sponges containing latrunculin A when compared with a
sponge lacking the compound. This could provide hints on which bacterial species are
more probable to be the compound’s producer. However, a similar taxonomic profile was
found between Chdi15Bu13SL+ and Chan15Bu13SL-, with Chan15Bu6SL+ showing a
significantly different microbiome. Therefore, from this analysis it is not possible to form
strong conclusions on potential latrunculin A producers. Nevertheless, this data is an
excellent opportunity to better understand the biotechnological potential of these
sponges’ symbionts and therefore some points are discussed next.
Gammaproteobacteria was the most predominant class of bacteria in all tree sponge
samples. Belonging to the phylum Proteobacteria, this class is known for the synthesis of
diversified secondary metabolites and for its wide presence  in sponges [30].
Interestingly, in recent years the number of interesting natural products identified from
marine proteobacteria has significantly increased. However, it is stated that the full
potential of this phylum, particularly in terms of PKS and NRPS genes, is far from being
deeply explored [99].
The phylum Actinobacteria is also very predominant in these sponges’ microbiomes. This
is a highly studied phylum, being its members the source of half of the bioactive
secondary metabolites discovered so far [32]. In terms of marine actinomycetes, recent
studies have shown significant differences on the produced secondary metabolites, when
compared with the ones produced by terrestrial actinomycetes. The strong bioactivities of
some discovered compounds shed light to the unexploited potential of this group of
marine bacteria [100].
The similarity between Chdi15Bu13SL+ and Chan15Bu13SL- is well evident at species
level, both having the Candidatus Solibacter usitatus as the most predominant bacterial
species (Table 17). This is an Acidobacteria of the class Solibacteres with a significant
abundance in these two sponges. Interestingly, recent studies have revealed the
widespread presence of PKS genes across the Acidobacteria phylum, the most abundant
on the planet. However, even though these polyketides are speculated to possess
significant antibacterial activities, their identification and characterization are still absent
[101]. It is expectable that in the following years more compounds from this phylum will
be discovered.
In Chdi15Bu6SL-, the higher number of reads at species level corresponded to Xylella
fastidiosa (332 reads). This Gammaproteobacteria species is described as a plant
pathogen that colonizes the xylem [102]. Therefore, its presence in a sponge microbiome
is highly unexpected and this sequencing result must be evaluated. Although 16S rRNA
based techniques are highly used for microbiome profiling, they have some associated
limitations that can lead to incorrect species identification. 16S rRNA gene sequencing is
known to provide genus identification in over 90% of the cases but only 65 to 83% of the
times can define bacterial species. These difficulties can be explained by the low
numbers of sequences deposited in the databases, the presence of novel taxa and the
mistaken classification of species with similar 16S rRNA sequences [103]. In addition, the
short length of obtained reads and sequencing errors can contribute to incomplete, or
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even incorrect, microbiome profiling [54]. This could have been the case of the
identification of Xylella fastidiosa in this sponge. Second, it can be speculated that
contamination of the sample with algae symbionts could have occurred.
The three organisms only identified on latrunculin containing sponges are anaerobic
bacteria. At the light of the long scientific believe that anaerobic bacteria are not capable
of producing the natural products of interest, these would be considered not worthy of a
deeper investigation. However, in recent years, several gene clusters for secondary
metabolites like polyketides and NRP have been found in genomes of anaerobic bacteria.
Hertweck et al. states that considering the limited energy available for anaerobes, the
produced compounds must have an important role on their survival [104]. Therefore, it is
estimated that, in next years, along with the increase on the number of anaerobic bacteria
sequenced, more BGCs for compounds with interesting bioactivities will be found.
An antiSMASH analysis was conducted in the closest available genomes of the
organisms presented in Table 20. However, no meaningful results were retrieved. It is
important to acknowledge that it is only possible to analyse available genomes of each
species and not the specific strains present in the sponge sample. Therefore, significant
differences on the BGCs content can be found. For example, while a given sponge’s
symbiont can possess a BGC, its closely-related strain present in databases may not.
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5 Conclusions
5.1 Summary of contributions
The main goal of this work was to provide insights on the biosynthetic pathway of
latrunculin A, a potent cytotoxic natural compound found in sponges. To achieve this, a
multi-approach analysis of sponge samples containing this compound was planned. This
consisted on the production of a metagenomic library of a sponge containing latrunculin
A, the screening of the metagenomic DNA of several sponge samples for conserved
domains of PKS and NRPS genes and on the bacterial taxonomical profiling of three
different sponge samples.
A metagenomic library was produced through transformation of a fosmid vector carrying
metagenomic DNA into host cells, following an alternative approach (electroporation and
heat-shock). This approach produced significantly less clones than the established
method (vector packaging in phage  particles followed by transduction into host cells).
Therefore, it is concluded that despite being possible to transform large vectors into
E. coli cells through electroporation and heat-shock, it does not produce a sufficiently
high number of clones to probabilistically contain the BGC of interest.
Additionally, the KS-PCR screening of the metagenomic DNA confirmed the presence of
diverse PKS genes. This approach, combined with taxonomical profiling through
16S rRNA gene sequencing, enlightened the biosynthetic potential of the sponges’
symbionts. Comments on the main characteristics of the most predominant bacteria are
provided.
5.2 Directions for future work
The work here developed provides a starting point to the search of the biosynthetic gene
cluster of latrunculin A through a metagenomic approach. The produced metagenomic
library shall be screened for conserved biosynthetic genes. Particularly, KS primers
designed from sequences present in the metagenome shall be used.
The described difficulties on producing a large metagenomic DNA library mandate a
consideration of different approaches and, therefore, several guidelines are hereafter
provided:
- Use of pulse field gel electrophoresis on the extraction of HMW metagenomic
DNA for library production. This method can tackle the limitations of standard gel
electrophoresis in separating large DNA molecules, thus enhancing the chances
of recovering higher molecular weight DNA, with better quality and yield.
- In future expeditions of the group, the metagenomic library should be constructed
as soon as possible after sponges’ samples collection. In addition, it could be
useful to analyse other sample conservation methods, rather than ethanol, to
maximize DNA preservation.
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- Whole genome sequencing for assembling of the information into contigs. This
would provide enough information to verify if parts of the putative latrunculin BGC
are encoded in the sponge metagenome.
- Construction of a second metagenomic library with the knowledge gathered in this
work for these specific samples. As referred by several research groups,
metagenomic library production is most part of the times a try-out process to
gather enough information on what the necessary procedure’s optimizations for
the samples’ specific characteristics are.
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A2. Translated protein sequences of KS-PCR products
>A.3334.3
ALEDAGYSPSSLWGSKTALFIATASSGYADQVTKYTDDTDGYSSTGTVPSIGPNRISYYL
NLHGPSEPIETACSSSLVAIHRGVSAIRQGEAEQAIVGGINLIVSPETHVSFTKAGMLSED
GRCKTFSSQANGYVRGEGVGMLYLKPLDSARRDKDTIHGVILGSAE
>A.1920.2
SAVGFNVASELVNTACSSSLVAIHRAINSLHNRESDVAVAGGVSMMLTPKTMLDASQLS
MLSPEGRCKTLDRDANGFVKGEGIGAVVLKPLVQALADGDAVYGVIRGSSVNHGGRAN
SLTAPNPKAQAALVAQAHRLAGFAPETIGYIEAHGT
>A.1920.5
PNRMSFFLNIHGPSEPIETACSSSLVAIHHAILAMNSNGCEMAIAGGVHAIVTPVAHISFSK
AKALAKDGRCKTFSPWADGFAIAEGVGMLILKRLSHAERSGDHIYGIIRGTAVNHGGRAN
SPTAPNPVAQADLLKAAYINAGVDPRTVGYIETHGT
>A.1933.A
MIANRISYLFDFHGPSAAVDTDSAGKNSGAHGAVSRLTRLERTAGLFSTPPLPMTSIFKM
LARGAHMMETETKCSPFIAPGNLHVFCSCVHSCVFRIHGHASTEKKQVALNPLRM
>A.1933.E
SDVAGPGGVSMLWRDTTMLDACHKSMLSPEGRCKTLARESRVLVEGGVAGEVVEKPL
VQASRIYRNSRHNRIX
>A.1933.I
CAVGFDIASELVNTACSSSLVAIHRAINTLHNRESDVAVLGGESMSGGRNPSWMHASTS
CFLQKVVARRLTGCGGCYDRGNRRQGRRTTRGAIIHWIYRNPRHNRSTPAAMAAA
>B.1920.4
FANRISYTFNLTGPSVTIDTACSSSLTAVDTACRELAAETVDAAFAGGANAILLPESYIEFS
RASMLSVSGRCHAFDENADGFVRAEGGALVLLKRLSDALADGDRIHATILATSTNQDGH
TASLMTPSVNSQKAMMHNALQRGEVAPKEIGYIETHGT
>B.1933.2
MRNRQSTTSATMVHSRTPYDSPDSVTTRFRLAQTLQNNDSATFASYIAVCRSIKTLTSR
RTV
>B.1933.4
IANRISYTFNLTGPSVTIDTACSSSLTAVDTACRELAAETVDAAFAGGANAILLPESYIEFS
RASMLSVSGRCHAFDENADGFVRAEGGALVLLKRLSDALADGDRIHATILATSTNQDGH
TASLMTPSVNSQKAMMHNALQRGEVAPKEIGYIEAHGT
72
>B.3420.3
CLGRRGLDPDRLKGSRTGVYTGISNDEYRMLVVDSSKPPEAAGSLYALSGTNLNGTSG
RVSFVLGLMGPAKAVDAACASAMVAVDDAVADLQQGKADLAIAGGVQAILNGRIYELRA
EAMMLSPDGQCKTFDASANGYVRGEGCGVVVLKRLSEAEADGDRIWTVIRGSAVNNG
GTSVGLTVPHTPALVQVMEAALSDAGVVPSEVGYIEIHGTNPAAMATGAVNSAHPX
>B.3420.5
XLDPDRLKGSRTGVYTGISNDEYRMLVVDSSKPPEAAGSLYALSGTNLNGTSGRISFVL
GLVGPAKAVDAACASAMVAVDDAVADLQQGKADLAIAGGVQAILNGRIYELRAEAMMLS
PDGQCKTFDASANGYVRGEGCGVVVLKRLSEAEADGDQIWTVIRGSAVNNGGTSVGLT
VPHTPALVQVMEAALSDAGVVPSEVGYIEAHGT
>C.2.1933
EAQAMDPQQRFFLECAWEALEDAGHLPDACNGRIGLYAGMAISTYLFHLISTGYLDLNN
FIHDSSDLLRVLIGNSKDQLATRASYKLNLTGPSISVQTACSTSLVAVTLACQGLLDY
STOP
DMALAGGVSIRLPQTVGYHYEEDGILSRDGHCRPFDVNAQGTVFGNGLGIVVLKRLEDA
LADYDHIYAVIKGFAVNNDGKEKVGYTAPSVNGQARVVAEALAMADVPPESISYVEAHG
TGTTLGDP
>C.2.3420
EAEDMDPQQRFFLECAWEALEDAGHLPDACNGRIGLYAGMAISTYLFHLISTGYLDLNN
FIHDSSDLLRVLIGNSKDQLATRASYKLNLTGPSISVQTACSTSLVAVTLACQGLLDYQCD
MALAGGVSIRLPQTVGYHYEEDGILSRDGHCRPFDVNAQGTVFGNGLGIVVLKRLEDAL
ADYDHIYAVIKGFAVNNDGKEKVGYTAPSVNGQARVIAEALAMADVPPESISYVEAHGTG
TSLGDP
>C.3.1933
GRGVDPDRLKGSRTGVYTGISNDEYRMLVVDSSKPPEAAGSLYAISGTNLNGTSGRVSF
VLGLMGPAKAVDAACASAMVAVDDAVADLQQGKADLAIAGGVQAILNGRIYELRAEAMM
LSPDGQCKTFDARRTDIAGRRFWGGCPQEVERRGGGWRLRYGSSSGAMAEATVGSA
SVGGSRTPPRWCR
>C.5.1920
RGIALEDAGYLPDACNGRIGLYAGMTISTYLFHLISTGYLDLNNFIHDSSDLLRVLIGNSKD
QLATRASYKLNLTGPSISVQTACSTSLVAVTLACQGLLDYQCDMALAGGVSIRLPQTVGY
HYEEDGILSRDGHCRPFDVNAQGTVFGNGLGIVVLKRLEDALADYDHIYAVIKGFAVNND
GKEKVGYTAPSVNGQARVIAEALAMADVPPESISYIEAHGT
>C.1920.5
IANRISHTFNLTGPSVTIDTACSSSLTAVDTACRKLAAETVDAAFAGGANAILLPESYIEFS
RASMLSVSGRCHAFDENADGFVRAEGGALVLLKRLSDALADGDRIHATILATSTNQDGH
TASLMTPSVNSQKAMMHNALQRGEVAPKEIGYIETHGT
>D.1920-1.2
HGKHKNTFGATFMVADVFKCRTFDERADGYVGGEGYGAIFIKPLAMAEVDGNQIYAIVK
ATAENHVGKATMLTAP
>D.3334-8
XLRLMTQGIIGGVYHRQSAPVFIRLRQGYYIWYFNGDELHSLELMGGSPSILASLISYYLN
LQGPAVATDTPCSSSLVPIHQACHSIQSRESEMVIAGGVYVMTTAQMYIMTL
